 REHOVOT, Israel, May 12, 2021 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ: KMDA; TASE: KMDA.TA, a plasma-derived biopharmaceutical company, today announced financial results for the three months ended March 31, 2021. 